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KB/Akt and serum and glucocorticoid–regulated kinase
(SGK) family kinases are important downstream tar-
gets of phosphatidylinositol 3 (PI-3) kinase and have
been shown to mediate a variety of cellular processes, in-
cluding cell growth and survival. Although regulation of
Akt can be achieved through several mechanisms, includ-
ing its phosphoinositide-binding Pleckstrin homology (PH)
domain, how SGK kinases are targeted and regulated re-
mains to be elucidated. Unlike Akt, cytokine-independent
survival kinase
 
 (
 
CISK)/SGK3 contains a Phox homology
(PX) domain. PX domains have been implicated in several
cellular events involving membrane trafﬁcking. However,
 
their precise function remains unknown.
 
 
 
We demonstrate
P
 
here that the PX domain of CISK interacts with phosphati-
 
dylinositol (PtdIns)(3,5)P
 
2
 
, PtdIns(3,4,5)P
 
3
 
, and to a lesser
extent PtdIns(4,5)P
 
2
 
. The CISK PX domain is required for
targeting CISK to the endosomal compartment. Mutation in
the PX domain that abolished its phospholipid binding
ability not only disrupted CISK localization, but also re-
sulted in a decrease in CISK activity in vivo. These results
suggest that the PX domain regulates CISK localization and
function through its direct interaction with phosphoinositides.
Therefore, CISK and Akt have evolved to utilize different lipid
binding domains to accomplish a similar mechanism of ac-
tivation in response to PI-3 kinase signaling.
 
Introduction
 
PI-3 kinase has been shown to mediate a variety of pathways
that regulate many aspects of the cell, including cell growth,
differentiation, membrane trafficking, and cytoskeletal dy-
namics (Chang et al., 1997; Fruman et al., 1998; Odorizzi et
al., 2000). PI-3 kinase phosphorylates the D-3 position of
the inositol ring of phosphoinositides in cells, thereby gener-
ating multiple phospholipid products: phosphatidylinositol
(PtdIns)*(3)P, PtdIns(3,4)P
 
2
 
, and PtdIns(3,4,5)P
 
3
 
. These
products serve as messengers for further downstream signal-
ing events (Rameh and Cantley, 1999). One such event is
the recruitment of signaling proteins that contain phospho-
inositide binding domains such as the Pleckstrin homology
(PH) and the FYVE domains to sites of D3-phosphoinosi-
tide synthesis (Patki et al., 1997; Bottomley et al., 1998;
Burd and Emr, 1998). For instance, 3
 
 
 
-phosphoinositide–
dependent kinase 1 (PDK1) is activated upon binding of
 
PtdIns(3,4,5)P
 
3
 
 to its PH domain (Alessi et al., 1997; Stephens
et al., 1998). Consequently, PDK1 transactivates a large col-
lection of protein kinases, including PKB/Akt and serum
and glucocorticoid–regulated kinase
 
 (
 
SGK) family members.
PKB/Akt, the cellular counterpart of v-Akt, has been im-
plicated in the regulation of cell survival in mammalian cells
(Chan et al., 1999; Datta et al., 1999). Akt contains a PH
domain NH
 
2
 
-terminal to its Ser/Thr kinase domain. The
Akt PH domain has been shown to preferentially bind
PtdIns(3,4)P
 
2
 
 and PtdIns(3,4,5)P
 
3
 
 (James et al., 1996;
Franke et al., 1997). As a result of this phospholipid bind-
ing, the conformation of Akt may be altered for subsequent
effective phosphorylation by PDK1. Furthermore, Akt is re-
cruited to the membrane, where it is colocalized with and
activated by PDK1 (Chan et al., 1999). In comparison, little
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is known about how SGK family kinases are targeted to
PDK1.
We have recently cloned an SGK family kinase cytokine-
independent survival kinase
 
 (
 
CISK)/SGK3 that shares signif-
icant homology with Akt in the kinase domain (Liu et al.,
2000). Several lines of evidence suggest that CISK may be
regulated in a similar fashion as Akt: (a) the two regulatory
sites (TFCG and FXXFSY) which are modulated by PDK1
in Akt and SGK are also conserved in CISK (Kobayashi and
Cohen, 1999; Park et al., 1999; Liu et al., 2000). (b) Similar
to Akt, CISK is a survival kinase that can also protect IL-3–
dependent cells from apoptosis induced by IL-3 withdrawal
(Songyang et al., 1997; Liu et al., 2000). (c) CISK functions
downstream of the PI-3 kinase cascade and phosphorylates
several Akt substrates, including the forkhead family of tran-
scription factor FKHRL1 (Brunet et al., 1999; Kops et al.,
1999; Liu et al., 2000). These observations indicate that
CISK may function in parallel to Akt. However, the subcel-
lular localization of CISK is different from that of Akt. In
contrast to Akt, CISK contains a Phox homology (PX) do-
main NH
 
2
 
-terminal to its kinase domain. Although PX do-
mains have been shown to mediate homotypic interactions
(Haft et al., 1998), whether they bind phosphoinositides is
not known. Interestingly, PX domains have been found in
many proteins that mediate membrane functions (e.g., sort-
ing nexins [SNX] in vesicular trafficking, and Vps5p and
Vps17p in vacuolar protein sorting) (Ekena and Stevens,
1995; Ponting, 1996; Horazdovsky et al., 1997; Nothwehr
and Hindes, 1997; Haft et al., 1998).
 
 
 
In the case of CISK,
the PX domain appears to be important for targeting CISK
to vesicle-like structures (Liu et al., 2000).
The similarities between CISK and Akt and the subcellu-
lar localization of CISK led us to propose that the CISK PX
domain may also bind phospholipids. In a manner similar to
the Akt PH domain, the lipid binding ability of the CISK
PX domain may be required for correctly targeting CISK to
its subcellular compartment and for regulating CISK activ-
ity. To this end, we investigated the lipid binding ability of
CISK PX domain and demonstrated that it could indeed
bind phosphoinositides. Furthermore, this binding was im-
portant for both CISK subcellular localization and activity.
These data strongly suggest that CISK has evolved to utilize
a different domain to accomplish similar regulation com-
pared with Akt.
 
Results and discussion
 
CISK is colocalized with early endosome autoantigen 1 
(EEA1) in the endosome
 
CISK is a PX domain–containing Ser/Thr kinase that be-
longs to the SGK family of kinases (Liu et al., 2000). The
exact function of PX domains is not yet known. Most PX
domains are found in proteins involved in trafficking, such
as SNXs (Ponting, 1996). Consistent with this observation,
we have found CISK to localize in vesicle-like structures (Liu
et al., 2000). Such localization is distinct from that of Akt
(Andjelkovic et al., 1997) and suggests that the PX domain
may play an important role in targeting CISK. Further ex-
amination of these vesicles revealed that CISK was targeted
to the endosomal compartments. As shown in Fig. 1, CISK
(green) was found to colocalize with the endosome marker
human EEA1 (red, Fig. 1 A), but not the lysosomal marker
lysosomal membrane glycoprotein (LAMP) (red, Fig. 1 B).
Colocalization of hemagglutinin (HA)-CISK and EEA1 was
also verified by deconvolution immunofluorescence micros-
copy. Because EGF-bound EGF receptors (EGFRs) interact
with SNX1 and are sorted by multivesicular bodies (MVBs)
formed by endosomal membranes (Haigler et al., 1979; Fut-
ter et al., 1996; Kurten et al., 1996), we examined if EGF
would colocalize with CISK-containing vesicles. At 
 
t
 
 
 
 
 
 0,
EGF was bound to EGFR at the cell surface (arrowheads,
Fig. 1 C). At 37
 
 
 
C, EGF is rapidly internalized. Interest-
ingly, as early as 5 min after EGF addition, vesicles that con-
tained both EGF and CISK could be detected. After 15 min,
Figure 1. CISK is localized to endoso-
mal compartments. COS-7 cells tran-
siently transfected with HA-epitope–
tagged CISK were examined for the 
localization of (A) CISK (green) and 
endogenous EEA1 (red), and (B) CISK 
(green) and endogenous LAMP (red). 
Merged images are shown on the right. 
(C) Texas red–conjugated EGF was added 
to COS-7 cells expressing HA-CISK. The 
subcellular localization of CISK (green) 
and the migration of EGF (red; arrow-
heads) was examined at 0, 5, and 15 
min after EGF addition at 37 C. The 
migration of EGF with CISK-containing 
vesicles is indicated by arrows. 
 
 
PX domain and phosphoinositides regulate CISK |
 
 Xu et al. 701
 
most of the EGF appeared to transit through the CISK-con-
taining vesicles (arrows). These observations suggest that
EGF enters cells via receptor-mediated endocytosis and then
enters the CISK-containing endosome compartment.
 
The CISK PX domain binds phosphoinositides
 
Akt contains a COOH-terminal kinase domain and an
NH
 
2
 
-terminal PH domain that binds to PtdIns(3,4)P
 
2
 
 and
PtdIns(3,4,5)P
 
3
 
, which in turn targets Akt to the membrane
(Franke et al., 1997). In addition to sharing 51% of se-
quence identity with Akt, CISK exhibits similar domain or-
ganization as Akt. In place of the PH domain is the PX do-
main. Our data implicate the PX domain of CISK in
specifically targeting CISK to vesicles. These observations
point to the intriguing possibility that the PX domain of
CISK may also bind phospholipids, thereby targeting and
regulating CISK activity.
To test this possibility, we investigated the binding of
CISK PX domain to a collection of phospholipids. Consis-
tent with our hypothesis, CISK could indeed bind phospho-
inositides, but not phosphatidic acid, phosphatidylserine,
phosphatidylethanolamine, PtdIns, or phosphatidylcholine
(Fig. 2 A). The sequence alignment of multiple PX domains
suggests that residue R90 is most conserved among PX do-
mains (Fig. 2 B) and may be necessary for phospholipid
binding. To further determine the relative preference of the
CISK PX domain to various phosphoinositides, wild-type
and mutant (R90A) glutathione 
 
S
 
-transferase (GST)-PX fu-
sion proteins were used to probe arrays containing different
concentrations of phospholipids. As shown in Fig. 2 C, the
CISK PX domain could specifically interact with Ptd-
Ins(3,5)P
 
2
 
, PtdIns(3,4,5)P
 
3
 
, and to a lesser extent Ptd-
Ins(4,5)P
 
2
 
, whereas the R90A mutation greatly diminished
the binding. These results demonstrate that the PX domain
of CISK could directly interact with specific phosphoinosi-
tides. The observation that the CISK PX domain selectively
bound PtdIns(3,5)P
 
2
 
 but not PtdIns(3,4)P
 
2
 
 might explain
the differential subcellular localization of CISK and Akt.
 
The PX domain is responsible for targeting CISK
 
Because the CISK PX domain could bind PtdIns(3,5)P
 
2
 
 and
PtdIns(3,4,5)P
 
3
 
, we speculated that such binding might be
essential for the subcellular localization of CISK. CISK colo-
calizes with EEA1, a protein shown to be targeted to the en-
dosomes through interaction with PtdIns(3)P via its FYVE
domain (Patki et al., 1997; Burd and Emr, 1998; Simonsen
et al., 1998). Since the production of D3-phosphoinositides
is dependent on PI-3 kinase, we first examined CISK local-
Figure 2. The CISK PX domain can specifically 
bind phosphoinositides. (A) The ability of the CISK 
PX domain to bind lipids was tested by a protein/
lipid overlay assay using GST-CISK PX domain 
fusion proteins and nitrocellulose-immobilized 
phospholipid strips (100 pmole/spot). PtdIns, phos-
phatidylinositol; PE, phosphatidylethanolamine; 
PC, phosphatidylcholine; PA, phosphatidic acid; 
PS, phosphatidylserine. (B) Sequence alignment of 
the PX domains from CISK, SNX16, SNX1, Mvp1p, 
Vps5, PI-3 kinase, and p40phox. Asterisk indicates 
conserved Arg residues. (C) The lipid binding abili-
ties of the wild-type (left) and mutant (R90A; 
middle) CISK PX domain were examined using 
nitrocelluose-immobilized phosphoinositide arrays 
(100–1.6 pmole/spot with twofold dilution). The 
triangles indicate decreasing concentration. The 
expression of the GST fusion proteins is shown on 
the right. 
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ization upon treatment with the PI-3 kinase inhibitor wort-
mannin. As shown in Fig. 3 A, the endosomal distribution
of CISK was disrupted over time upon wortmannin treat-
ment. At 40 min after treatment, vesicular distribution of
CISK was no longer detectable. Therefore, the localization
of CISK to the endosomes likely requires D3-phosphoinosi-
tides, consistent with our result that the CISK PX domain
preferentially binds D3-phosphoinositides PtdIns(3,5)P
 
2
 
 and
PtdIns(3,4,5)P
 
3
 
. In addition, deletion of the PX domain
abolished the vesicular localization of CISK (Fig. 3 B). Fur-
thermore, the CISK mutant (R90A) that failed to bind
phospholipids was not targeted to the endosomes (Fig. 3 B).
In contrast, full-length kinase-dead CISK with a mutation
in the ATP binding site still localized to the vesicles (data
not shown), suggesting that the kinase activity is not re-
quired for CISK targeting. These data combined indicate
strongly that the PX domain of CISK is crucial in regulating
the endosomal localization of CISK, and this regulation is
most likely phosphoinositide-dependent.
 
The PX domain serves to regulate the activity of CISK
 
We have demonstrated that the PX domain is required for
phospholipid binding and endosomal localization of CISK.
Next, we investigated if the PX domain–lipid interactions
were also important for regulating the kinase activity of
 
CISK. We have shown previously that one of the potential
downstream targets of CISK is FKHRL1 (Liu et al., 2000).
Phosphorylation of FKHRL1 by Akt and SGK kinases in-
hibits transcription activity of FKHRL1 by increasing its nu-
clear export, which may result in a decrease in FasL expres-
sion and hence promote cell survival (Biggs et al., 1999;
Brunet et al., 1999, 2001). To test the hypothesis that the
PX domain is important for the function of CISK, we exam-
ined the inhibition of FKHRL1 activity by CISK and its PX
domain mutants using a luciferase reporter assay in 293T
cells. As reported previously (Liu et al., 2000), CISK ap-
peared to inhibit FKHRL1 activity in a dose-dependent
manner (Fig. 4). This inhibition was enhanced significantly
with the deletion of the PX domain, indicating that the PX
domain may negatively regulate CISK activity. In contrast,
the R90A mutation abolished the inhibition of FKHRL1 by
CISK, suggesting that phosphoinositide binding may be
crucial for CISK function in vivo. These data point to a
model where lipid interaction may be required for the acti-
vation of CISK or colocalization of CISK to its substrates.
Regulation of SGK family kinases has been shown to oc-
cur through the phosphorylation of the conserved T-loop
(TFCG) and hydrophobic (FXXFSY) motifs that are also
found in CISK (Kobayashi et al., 1999; Liu et al., 2000).
The phosphorylation and subsequent activation of these ki-
Figure 3. The lipid-binding PX domain is important for CISK localization. (A) The vesicular subcellular localization of CISK is disrupted af-
ter wortmannin treatment. 3T3 cells expressing HA-tagged wild-type CISK were treated with wortmannin (100 nM) for 0, 15, 30, or 40 min 
before fixation for immunostaining analysis. (B) The localization of HA-tagged wild-type CISK, CISK- PX, and CISK-R90A mutants in 3T3 
cells was compared. 
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nases has been shown to be mediated by the PDK1 kinase.
PDK1, an important downstream effector of the PI-3 kinase
cascade, consists of an NH
 
2
 
-terminal kinase domain and a
COOH-terminal PH domain. The PDK1 PH domain inter-
acts with several phosphoinositides, including PtdIns(3,4,5)P
 
3
 
and PtdIns(3,4)P
 
2
 
, and therefore likely mediates the target-
ing of PDK1 to the membrane (Anderson et al., 1998;
Stephens et al., 1998; Currie et al., 1999). We have shown
previously that CISK is able to protect cells from apoptosis
induced by growth factor withdrawal, and that CISK activa-
tion is wortmannin-sensitive (Liu et al., 2000). Therefore,
CISK activation and survival activity may be accomplished
through the binding of the CISK PX domain with phospho-
inositides such as PtdIns(3,4,5)P
 
3
 
, thereby targeting CISK to
the membrane where PDK1 is located. Because EGF is also
internalized through the CISK endosomal compartment, it
is possible that active PI-3 kinase and PDK1, which are asso-
ciated with EGFRs, are also recruited to the same compart-
ment. In addition to PtdIns(3,5)P
 
2 
 
and PtdIns(3,4,5)P
 
3
 
, the
CISK PX domain binds with a lower affinity to Ptd-
Ins(4,5)P
 
2
 
. We speculate that CISK may interact with the
plasma membrane in unstimulated cells. Upon PI-3 kinase
activation, a high level of PtdIns(3,5)P
 
2 
 
and PtdIns(3,4,5)P
 
3
 
may concentrate CISK in the endosomes.
Our data suggest that CISK and Akt have used different
lipid binding domains to accomplish a similar mechanism of
 
activation in response to PI-3 kinase signaling. Although
sharing some similarities, CISK may be regulated and func-
tion distinctly from Akt. Studies of Akt have shown that Akt
translocates to the plasma membrane, where it is activated
upon PI-3 kinase activation and then migrates into the nu-
cleus (Andjelkovic et al., 1997). In comparison, in growing
cells CISK is mainly present in the endosomal compart-
ments with weak nuclear staining. Both disassociation from
endosomes and nuclear import may be necessary for CISK
to regulate FKHRL1. Deletion of the PX domain may en-
hance nuclear import, which may explain why HA-CISK-
 
 
 
PX is more active in inhibiting FKHRL1. Furthermore,
the Akt PH domain and the CISK PX domain appear to
have different preferences for phosphoinositides. Such dif-
ferences may determine both their subcellular localization
and the potential substrates that they act upon in vivo.
Different from Akt, it is possible that CISK may regulate
vesicle trafficking and thereby modulate the number of acti-
vated receptors in the cell. Activated EGFRs, upon binding
with EGF, are internalized and targeted for vacuolar degra-
dation. Such membrane protein sorting is thought to occur
within MVBs which form through invagination of the endo-
somal membrane (Futter et al., 1996; Odorizzi et al., 2000).
Our observation of the comigration of EGF with CISK-con-
taining vesicles suggests that CISK may be similar to SNX1
in the degradation process of activated receptors (Kurten et
al., 1996). This hypothesis is consistent with our finding
that the CISK PX domain preferentially binds to Ptd-
Ins(3,5)P
 
2
 
 and PtdIns(3,4,5)P
 
3
 
. In yeast and mammalian
cells, the Fab1p kinase and its mammalian homologue PIK-
fyve function as PtdIns(3)P-5 kinases to generate Ptd-
Ins(3,5)P
 
2
 
, and have both been implicated in membrane
trafficking (Yamamoto et al., 1995; Cooke et al., 1998; Gary
et al., 1998; Ikonomov et al., 2001). In addition, in yeast,
PtdIns(3,5)P
 
2
 
 appears to be required for controlling MVB
sorting to the vacuole/lysosome (Odorizzi et al., 1998). The
direct downstream mediators of PtdIns(3,5)P
 
2
 
 remain un-
known. Given that CISK binds PtdIns(3,5)P
 
2
 
 and localizes
to the relevant compartment, CISK might represent one of
the targets of Fab1p and its homologues that are involved in
endosome–MVB fusion with lysosomes.
 
Materials and methods
 
Constructs and cell lines
 
Full-length or mutant CISKs were cloned into the pcDNA3 or pBabe-puro
vector (Liu et al., 2000). All constructs were engineered to be HA tagged.
The HA-CISK-
 
 
 
PX mutant was generated by deleting the first 140 amino
acids of CISK. The HA-CISK R90A mutant was generated by mutating res-
idue Arg90 of CISK to Ala using the Quikexchange mutagenesis kit (Strat-
agene). 293T or COS-7 cells were transiently transfected with pcDNA
constructs encoding either wild-type or mutant CISK for luciferase assays
and immunostaining. Retroviruses were generated by transfecting BOSC23
cells with various pBabe-CISK constructs, and then used to infect 3T3
cells for immunofluorescence analysis as described previously (Liu et al.,
2000).
 
GST fusion proteins
 
To generate GST PX domain fusion proteins, sequences encoding the CISK
PX domain (amino acid 1–136) or CISK PX domain point mutant (R90A)
(generated using the Quikexchange mutagenesis kit; Stratagene) were
cloned into the pGEX4T-1 vector (Amersham Pharmacia Biotech), and
used to transform 
 
Escherichia coli
 
. Expression of fusion proteins was in-
duced by the addition of 0.2 mM IPTG. GST fusion proteins were purified
from bacterial lysates using glutathione-agarose beads (Molecular Probes).
Figure 4. The PX domain can regulate CISK activity. (Top) The 
activities of wild-type or mutant CISK were compared using 
luciferase assays. 293T cells were transiently transfected with a 
mock vector, FKHRL1 (50ng) alone, or FKHRL1 (50 ng) with either 
wild-type CISK (0.1 or 0.5  g), CISK- PX (0.1 or 0.5  g) or CISK-
R90A (0.1 or 0.5  g). Error bars indicate standard errors. (Bottom) 
The expression of various CISK constructs was examined by 
Western blotting with an anti-HA antibody. 
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Protein/lipid overlay assays
 
The protein/lipid overlay assays were performed as described (Dowler et
al., 1999). PIP-Strip™ and PIP-Array™ were purchased from Echelon, Inc.
For phospholipid binding, the strips or arrays were incubated overnight at
4
 
 
 
C with GST–PX domain fusion proteins (1 
 
 
 
g/ml) in TBST (10 mM Tris,
150 mM Nacl, and 0.1% Tween-20) with 3% fatty acid–free BSA (Sigma-
Aldrich). The membranes were then washed in TBST with 3% fatty acid–
free BSA and incubated with a monoclonal anti-GST antibody (Santa Cruz
Biotechnology, Inc.) for 1 h at room temperature. The membranes were
then washed in TBST, incubated with a HRP-conjugated anti–mouse anti-
body (Bio-Rad Laboratories), and visualized via ECL (Amersham Pharma-
cia Biotech).
 
Immunostaining
 
COS-7 and 3T3 fibroblast cells grown on coverslips were fixed in 2% para-
formaldehyde in 0.1 M phosphate buffer for 30 min, excess fixative was
neutralized using 0.15 M glycine/PBS. COS-7 cells were blocked using
2.5% fetal calf serum/PBS for 15 min. 3T3 cells were permeabilized with
0.5% Triton X-100 in PBS and blocked with 5% normal goat serum. Pri-
mary antibodies were applied in 1% BSA (Sigma-Aldrich) or goat serum in
PBS for 1 h at room temperature, followed by a corresponding Alexa 488–,
Alexa 594–conjugated (Molecular Probes), or FITC-conjugated (Sigma-
Aldrich) secondary antibody diluted 1:250 in 1% BSA/PBS for 30 min at
room temperature. Omission of primary antibodies was used as negative
control. The cells were also incubated with DAPI for 3 min at 25
 
 
 
C to stain
their nuclei. For experiments with EGF, Texas red–conjugated EGF (Molec-
ular Probes) was added for initiation of internalization. The cells were then
incubated at 37
 
 
 
C for various periods of time. The coverslips were washed
with PBS, mounted onto glass microscope slides and viewed using a ZEISS
Axioskop fluorescence microscope equipped with a Interline Transfer CCD
Camera (COHU, Inc.). For experiments using wortmannin, the cells were
first treated with 100 nM wortmannin for 0, 15, 30, or 40 min before fixa-
tion. Cell lysates were also Western blotted to confirm protein expression.
The antibodies used were: rabbit polyclonal anti-HA (1:200; Santa Cruz
Biotechnology, Inc.); mouse monoclonal anti-HA (1:1,000; Babco); mouse
monoclonal anti-EEA1 (1:100; Transduction Labs); and mouse monoclonal
anti-LAMP (1:200; Development Studies Hybridoma Bank).
 
Luciferase assays
 
Luciferase assays were carried out as described (Liu et al., 2000). 293T
cells were transiently transfected with various constructs at different con-
centrations. The total amount of transfected DNA was normalized using
pcDNA3. The reporter construct (50 ng/transfection) contains two copies
of insulin-responsive sequence from IGFBP-1 (Guo et al., 1999) in the lu-
ciferase construct pGL
 
2
 
. 
 
 
 
-gal (50 ng/transfection) was used as control to
normalize transfection efficiency. At 30 h posttransfection, the cells were
harvested to assay for luciferase activity as described in the manufacturer’s
manual (Promega). Cell lysates were also Western blotted using a mono-
clonal anti-HA antibody (Sigma-Aldrich) to confirm protein expression.
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